OU Internal Medicine Residency Oklahoma City, OK https://xitter.cf/t.co/fnAsPcYG9Z
Oklahoma City, OK
Joined October 2024
- Tweets106
- Following52
- Followers143
- Likes142
OU Internal Medicine Residency retweeted
Happy to present our research on screenable cancers in patients diagnosed during a hospital admission at #ASCOQLTY26
OU Internal Medicine Residency retweeted
@OU_internalmed at #ASCOQLTY26!! Dr @KoltonKardokus presented our work today of the inpatient palliative care use at @OUHealth for patients with cancer.
Kolton is in the hem/onc fellowship match this cycle & we are so proud of him! Any program would be lucky to match him!!⭐️⭐️⭐️
OU Internal Medicine Residency retweeted
Thank you @TheDrWood for your excellence in mentorship and guidance with this project!
Congratulations to excellent mentee & @DrMcClellandLab member Dr. @KoltonKardokus for first-authoring our work examining systemic tx for inpatients evaluated for the SPORTSMEN Phase II RCT!
He is currently applying in the #MedOnc match!
#SPORTSMENRCT
ovid.com/jnls/amjclinicalonc…
👏
Excited to see our review on device-based neuromodulation in heart failure featured by Cardiac Interventions! Grateful to my mentor, Dr. @MohitpahujaMD , for his continued guidance, and mentorship. @OUdoim @ResearchOU @OU_internalmed @OUCollegeofMed
OU Internal Medicine Residency retweeted
Excited to see our review on device-based neuromodulation in heart failure featured by Cardiac Interventions! Grateful to my mentor, Dr. @MohitpahujaMD , for his continued guidance, and mentorship. @OUdoim @ResearchOU @OU_internalmed @OUCollegeofMed
Drs. Yusra M. Nasir (@YusraMinahil), Khawaja H. Akhtar (@khawaja6216), & Mohit Pahuja (@MohitpahujaMD) examine device-based neuromodulation in HF, reviewing current & emerging therapies, patient phenotypes that may benefit most, and more. citoday.com/articles/2026-di…
OU Internal Medicine Residency retweeted
NEWS: University of Oklahoma College of Medicine has appointed Dr. Salar Faiazi, M.D., as Assistant Dean for Clinical Curriculum.
🔗 link.ou.edu/4yTCx7C
ALT This is an image of a person in a white coat with a stethoscope, associated with OU Health College of Medicine at the University of Oklahoma. The text reads "Salar Faiazi, M.D., Assistant Dean for Clinical Curriculum."
Congratulations, Dr. Soni! So well deserved. We are incredibly proud of you!👏🎉
Had an amazing time presenting our work at the OSCO conference today at @StephensonCC. Humbled and honored to receive 1st prize for our poster on SMAD4 alterations as a predictor of neoadjuvant chemotherapy response in PDAC. Always grateful to my mentor @Phase1Onc. @OU_internalmed
OU Internal Medicine Residency retweeted
Though it has been a few weeks since we bid a fond farewell to our graduates, we wanted to take the time to celebrate them a little more, and to wish them the best of luck in all their endeavors!
We can't wait to see how they continue shaping the future of medicine! #LeadOnOU
OU Internal Medicine Residency retweeted
Thank you so much for highlighting our work, @crisbergerot!
I am so excited to present about longitudinal coping among early phase cancer clinical trial participants at #ASCO26, and I am especially honored to have been awarded a @ConquerCancerFd for Merit Award for this work🥹
How patients cope during early-phase cancer clinical trials may matter beyond emotional wellbeing
Longitudinal changes in coping strategies were associated w QOL, symptoms, time on trial, and overall survival #ASCO26 @anhbl9
asco.org/abstracts-presentat…
OU Internal Medicine Residency retweeted
I am very honored to present this rapid oral abstract on behalf of Dr @LundquistDebra and our amazing team at #ASCO26!
I’m so deeply appreciative of Dr Lundquist and Dr @RyanNipp for your mentorship and our phenomenal team who took me in and supported me these past few years💛
Getting excited for #ASCO26 & so proud of Dr. Anh Lam (@anhbl9) for presenting at this year’s meeting!
“Longitudinal changes in patient-reported quality of life & hope among early phase cancer clinical trial participants.”
meetings.asco.org/meetings/2…
#PallOnc
@ASCO @OUCollegeofMed
OU Internal Medicine Residency retweeted
Lastly, thank you to the residents of our great program who elected us to be your Chiefs and trusted us to lead you & support you. This has been an incredibly transformative year, and it has been an honor for us to advocate for and work with you all this year🥹
OU Internal Medicine Residency retweeted
My co-chiefs and I presented at @OUdoim Grand Rounds this afternoon and shared many of our initiatives throughout our CMR year with @OU_internalmed!
What an honor it has been to serve our program and establish foundations to pave way for future residents🫶
OU Internal Medicine Residency retweeted
Thank you so so much to the amazing faculty & fellows we collaborated with this year, who work tirelessly to support our residents from the sim lab, to the research curriculum, fellowship bootcamp, and much much more. We couldn’t have been successful this year without you all.
OU Internal Medicine Residency retweeted
Grateful to have our work published in Reviews in Cardiovascular Medicine.
Thankful to Dr. Mattumpuram for his mentorship and to all collaborators for their valuable contributions to this project.
Read full article: imrpress.com/journal/RCM/27/…
📚 Journal Club Recap
Two weeks ago, we discussed:
“Bleeding Risk with Apixaban vs. Rivaroxaban in Acute Venous Thromboembolism”
Published in the New England Journal of Medicine
🔗 nejm.org/doi/full/10.1056/NE…
🤖 Made with AI
Key Takeaways:
1️⃣ Apixaban significantly reduces bleeding vs. rivaroxaban (RR 0.46; ARR 3.8%)
2️⃣ Pragmatic randomized trial design effectively addresses clinical equipoise in real-world settings
3️⃣ Recurrent DVT rates were similar (~1%), highlighting bleeding risk as a key driver in anticoagulant selection
#JournalClub #MedTwitter #Hematology #VTE #OUHealth